DXCM β€” DEXCOM INC COM

Ownership history in Hudson Value Partners, LLC  Β·  8 quarters on record

This page tracks every 13F SEC filing in which Hudson Value Partners, LLC reported a position in DEXCOM INC COM (DXCM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.56% (2024 Q1)
πŸ“Š Avg. % of fund
0.34%
πŸ“… First filed
2023 Q4
πŸ“… Last filed
2025 Q3
⏱ Quarters held
8

Position Intelligence

Hudson Value Partners, LLC Γ— DXCM AI Analytics

πŸ“‰ Hudson Value Partners, LLC underperformed the S&P 500 by –51.8% annually on this DXCM position. Timing score: 33% (1/3 decisions correct). Average cost basis: $138.70. Maximum drawdown during holding period: –51.7%.

πŸ“ˆ Position Alpha vs SPY
-51.8%
annualised excess return

❌ Significantly underperformed the S&P 500 by 51.8% ann.
6 quarters analyzed

⏱️ Timing Score
33%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
1 of 3 add/trim decisions correct

πŸ’° Entry Quality
$138.70
-51.5% vs current ($67.29)

Best entry: $138.70 (2024 Q1)  Β·  Worst: $138.70 (2024 Q1)

πŸ›‘οΈ Drawdown Resilience
–51.7%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
40%
buy-side decisions

2 adds Β· 3 trims. Bought during 0 of 4 down-price quarters. πŸ“‰ Predominantly trimming β€” distribution phase.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.12% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    DXCM price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 8 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 5,980 -2,000 -25.1% 0.12% $402K $67.29
2025 Q2 REDUCED 7,980 -1,540 -16.2% 0.24% $697K $87.29
2025 Q1 UNCHANGED 9,520 β€” 0% 0.24% $650K $68.29
2024 Q4 UNCHANGED 9,520 β€” 0% 0.28% $740K $77.77
2024 Q3 REDUCED 9,520 -40 -0.4% 0.25% $638K $67.04
2024 Q2 UNCHANGED 9,560 β€” 0% 0.46% $1.1M $113.38
2024 Q1 ADDED 9,560 +10 +0.1% 0.56% $1.3M $138.70
2023 Q4 INITIATED 9,550 β€” β€” 0.55% $1.2M β€”

🏒 Other funds also holding DXCM

As of 2025 Q4 β€” sorted by position size

MIG Capital, LLC 3Y 7Y 6.82% BRIDGER MANAGEMENT, LLC 3Y 7Y 4.35% Parkman Healthcare Partners LLC 3Y 3.71% Tri Locum Partners LP 3Y 3.63% SIRIOS CAPITAL MANAGEMENT L P 3Y 7Y 3.56% Soleus Capital Management, L.P. 3Y 3.18% Vestal Point Capital, LP 2.88% Alphabet Inc. 3Y 2.67% Intermede Investment Partners Ltd 3Y 7Y 2.48% ELLERSON GROUP INC /ADV 3Y 2.4%
← Back to Hudson Value Partners, LLC Holdings